Preferred Label : atosiban;

MeSH note : RN refers to (L-Thr, L-Orn)-isomer ; oxytocin and vasopressin antagonist;

CISMeF synonym : d(TVT); CAP 476; antocin; dE-TVT; dETVT; ORF-22164; RWJ-22164;

MeSH synonym : (Mpa(1)-D-Tyr(Et)(2)-Thr(4)-Orn(8))-oxytocin; 1-deamino-2-Tyr(OEt)-4-Thr-8-Orn-oxytocin; oxytocin, 1-deamino-O-ethyltyrosyl(2)-threonyl(4)-ornithine(8)-; oxytocin, 1-deamino-(O-Et-Tyr)(2)-Thr(4)-Orn(8)-; (Mpa(1),D-Tyr(Et)2,Thr(4),Orn(8))oxytocin;

MeSH hyponym : RWJ 22164; ORF 22164;

MeSH Related Number : 90779-69-4;

Registry Number MeSH : 90779-69-4;

Is substance : O;

UNII : 081D12SI0Z;

InChIKey : VWXRQYYUEIYXCZ-OBIMUBPZSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2967172/fr/atosiban-accord
2019
false
false
false
France
atosiban
treatment outcome
insurance, health, reimbursement
threatened premature labor
obstetric labor, premature
adult
pregnancy
evaluation of the transparency committee
atosiban
vasotocin
vasotocin

---
https://www.has-sante.fr/portail/jcms/c_2803492/fr/atosiban-ever-pharma
2017
false
false
false
false
France
French
evaluation of the transparency committee
atosiban
vasotocin

---
https://www.has-sante.fr/portail/jcms/c_2788641/fr/atosiban-stragen
2017
false
false
false
France
French
evaluation of the transparency committee
atosiban
vasotocin

---
http://www.has-sante.fr/portail/jcms/c_2756535/fr/atosiban-ever-pharma
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Product containing atosiban (medicinal product)
Atosiban 7.5mg/mL injection solution 0.9mL vial (product)
Atosiban 7.5mg/mL infusion concentrate 5mL vial (product)
atosiban
vasotocin

---
http://www.has-sante.fr/portail/jcms/c_2743215/fr/atosiban-accord
2017
false
false
false
France
French
evaluation of the transparency committee
atosiban
Atosiban 7.5mg/mL infusion concentrate 5mL vial (product)
drugs, generic
atosiban
vasotocin

---
http://www.has-sante.fr/portail/jcms/c_2590007/fr/atosiban-panpharma
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
atosiban
vasotocin

---
http://www.cochrane.org/fr/CD004452
2014
false
false
false
United Kingdom
France
barusiban
atosiban
tocolytic agents
barusiban
atosiban
tocolytic agents
treatment outcome
pregnancy
meta-analysis
french abstract
obstetric labor, premature
receptors, oxytocin
oligopeptides
vasotocin
vasotocin
oligopeptides
vasotocin

---
http://www.has-sante.fr/portail/jcms/c_1670200/fr/atosiban-sun
2013
France
evaluation of the transparency committee
atosiban

---
https://www.ema.europa.eu/medicines/human/EPAR/Atosiban-SUN
2013
United Kingdom
French
English
atosiban
atosiban
drug approval
europe
treatment outcome
atosiban
tocolytic agents
tocolytic agents
adult
Threatened premature labor (disorder)
obstetric labor, premature
infusions, intravenous
drugs, generic
breast feeding
hormone antagonists
hormone antagonists
clinical trials, phase iii as topic
receptors, oxytocin
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
vasotocin

---
https://www.ema.europa.eu/medicines/human/EPAR/Tractocile
2012
United Kingdom
English
French
syndication feed
tocolytic agents
obstetric labor, premature
treatment outcome
drug evaluation
vasotocin
atosiban
drug evaluation
package leaflet
summary of product characteristics
atosiban
atosiban
drug approval
europe
clinical trials, phase iii as topic
breast feeding
drug evaluation, preclinical
tocolytic agents
hormone antagonists
hormone antagonists
receptors, oxytocin
infusions, intravenous
injections, intravenous

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62476853
2012
France
summary of product characteristics
package leaflet
injections
atosiban

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61710552
2012
France
summary of product characteristics
package leaflet
atosiban

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.